Learn more about the people and groups that further research at the Joslin Diabetes Center  |  Select an application from the list below:  |  Search JoslinResearch.org  |  Learn about JoslinResearch.org and its features  |  Contact us with questions or to let us know about problems  |  Login to use all our features
Joslin Diabetes Center Website
  Harvard Medical School
Joslin Research Home  
Harvard Medical School Joslin Research Home
Welcome to the Joslin Research Website                     
 
  Joslin Investigator:
   
  
Beetham Eye Institute of the Joslin Diabetes Center
 
Investigator Specifics:
Professional Details:
Publications
CV not available

Member of Section:

Related Resources:
Section of Eye Research

 
 
Jerry D Cavallerano, OD, PhD, FAAO
BEI Assistant to the Director
Joslin Diabetes Center
Associate Professor
New England College of Optometry
 
5/1/1981 -  
 
 Optometrist

Jerry Cavallerano, OD, PhD, FAAO is staff optometrist and Assistant to the Director of the Beetham Eye Institute, Joslin Diabetes Center. He is Associate Professor of Optometry, New England College of Optometry, and Adjunct Clinical Professor, Pennsylvania College of Optometry. Dr. Cavallerano received his O.D. from the New England College of Optometry and his Ph.D. from Fordham University.



Dr. Cavallerano was a member of the Diabetes Control and Complications Trial research team that received the 1994 Charles H. Best Distinguished Service Award of American Diabetes Association. As editor of the New England Journal of Optometry he received awards for Most Improved Regional Journal in 1988 and Best Regional Journal in 1989.
Dr. Cavallerano has served as editor of the New England Journal of Optometry and on the editorial boards of Diabetes Spectrum and Clinical Diabetes. He is presently on the scientific editorial review board of Review of Optometry.



Dr. Cavallerano is a clinical co-investigator for the Eli Lilly sponsored Oral Treatment Diabetic Retinopathy Study in Patients with Diabetes Mellitus. He is also presently engaged in research programs using the Joslin Vision Network, the telemedicine initiative of the Beetham Eye Institute and the Joslin Diabetes Center. Dr. Cavallerano’s past clinical research activities include The Early Treatment Diabetic Retinopathy Study, Diabetic Macular Edema Study, Diabetes Control and Complications Trial, and the Sorbinil Retinopathy Trial.



Selected References:



Bursell S-E, Cavallerano JD, Cavallerano AA, Clermont AC, Birkmire-Peters D, Aiello LP, Aiello LM, Joslin Vision Network Research Team. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001; 108:572-585.



Aiello LM, Cavallerano J, Cavallerano A, Bursell S-E. The Joslin Vision Network (JVN) Innovative Telemedicine Care for Diabetes. Ophtahlmol Clin North Am. 13:2000; 213-224.



Aiello LM, Cavallerano JD, Aiello LP. Diagnosis, management, and treatment of nonproliferative diabetic retinopathy and diabetic macular edema. In Albert DM, Jakobiec FA (eds.). Principles and Practice of Ophthalmology, Second Edition. W.B. Saunders Co., Philadelphia, 2000, pp.1900-1914.



Barnett DM, Aiello LM, Niffenegger JH, Fong DS, Cavallerano JD. Diabetes Mellitus. In Albert DM, Jakobiec FA (eds.). Principles and Practice of Ophthalmology, Second Edition. W.B. Saunders Co., Philadelphia, 2000, pp.4525-4541.



Aiello LM, Cavallerano JD, Aiello LP, Bursell S-E. Diabetic Retinopathy. In Guyer DR, Yannuzzi LA, Chang S, Shields JA, Green WR (eds.). Retina-Vitreous-Macula. W.N Saunders Co. Philadelphia 1999, pp. 316-344.



Aiello LM, Bursell S-E, Cavallerano JD, Gardner WK, Strong J, Joslin Vision Network Research Team. Joslin Vision Network Validation Study: Pilot Image Stabilization Phase. J Am Optom Assoc 1998; 69:699-710.



Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL III, Klein R. Diabetic retinopathy (Technical Review). Diabetes Care 1998; 21:143-156.